Blog - Page 2947 of 5592

MondayApr 22, 2013 3:14 pm

The Guitammer Company (GTMM) Grows with an Idea Whose Time has Come

Companies that are pioneers, breaking new ground, perhaps even defining new industries, are almost always based less on a desire for money than a passion for a particular field. The Guitammer Company is an example. The company was founded by Ken McCaw, an accomplished bass player, composer, and producer, now on the Board of Directors. His personal passion for making music led him to tackle a common frustration experienced by bass players and drummers. He wanted to actually feel the low end frequencies without having to increase stage monitor volume so loud that it disturbed the rest of the band.…

MondayApr 22, 2013 1:28 pm

iBio, Inc. (IBIO) Achieves Critical Technology Transfer Milestone

iBio develops and offers product applications of its iBioLaunch and iBioModulator platforms. It provides collaborators full support for turnkey implementation of its technology for both proprietary and biosimilar products. In addition, the company is developing select product candidates that have been derived from the iBioLaunch platform. The company today announced the achievement of a critical technology transfer milestone verified by an independent third party laboratory. The validation milestone showed proof that an independent party, without any guidance or assistance from iBio, could use the iBioLaunch system to reliably produce commercial yields of targeted biopharmaceuticals. iBio's business commitments to its licensees,…

MondayApr 22, 2013 10:41 am

Rainbow Coral Corp. (RBCC) and the New World of Pharmacogenomics

Immunotherapy and stem cell technology represent two of the hottest fields in medical science today. Although there is still much research to be done, immunotherapy is seen as the ultimate weapon against some of the most intractable diseases, essentially having the best potential to hunt out and destroy bad cells. And stem cell technology is seen as the best hope for regenerating the body, essentially building more good cells. But there’s a third less known but no less important component to the future of modern medicine. It’s called pharmacogenomics, a field of study derived from the Human Genome Project. The…

MondayApr 22, 2013 10:35 am

Codexis, Inc. (CDXS) Video Chart for Monday, April 22, 2013

CDXS bounced off a support level at $2 three times in the past nine months to climb to a minimum of $2.66. Last week, the stock price hit that level again and then closed ahead on Friday by more than 5 percent, potentially signaling the start of another bounce/reversal. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

MondayApr 22, 2013 9:03 am

The Aristocrat Group Corp. (ASCC) Pursues Opportunities to Maximize Impact of New Vodka’s Launch

Today before the opening bell, The Aristocrat Group announced its executive leadership will be in Sin City this week to scout unique launch opportunities for vodka line set to be released by its brand management division, Luxuria Brands. Known for its attachment to fine spirits, Las Vegas is the perfect city for the ultra-premium spirit’s debut. “We’ll be speaking to club owners, beverage directors and other influential people in the Las Vegas restaurant and bar scene,” stated ASCC CEO Robert Federowicz. “We’re aiming to make as big a splash as possible with the release of our first distilled spirit, and…

MondayApr 22, 2013 8:40 am

Harbor Island Development Corp. (HIDC) to Launch New Print Marketing Campaign for Infusion Brands International's Dual Saw Destroyer

Harbor Island Development, through its wholly owned subsidiary BrandSeed Media Services LLC, a multi-channel direct marketing service provider, today announced plans to launch a new print marketing campaign for The Dual Saw(R) Destroyer, a product manufactured by Infusion Brands International (OTCQB: INBI), a global consumer products company. Using its expertise, The BrandSeed team will create a direct response marking platform focusing on nationwide print advertising in newspapers and magazines for Infusion Brands newest product, The Dual Saw Destroyer. This initial campaign will serve to validate the economics of a planned future rollout to millions of consumers through BrandSeed's nationwide print-infomercial…

MondayApr 22, 2013 8:36 am

USA Technologies, Inc. (USAT) to Showcase Cashless Payment Services at NAMA OneShow

Senior Vice President of Sales and Business Development, Michael K. Lawlor of USA Technologies, is set to present during two different sessions taking places at the NAMA OneShow being held in Las Vegas this April. USA Technologies is a leader of M2M telemetry solutions for self-serve retailing industries and wireless cashless payments. Lawlor’s first presentation titled, Technology’s Impact on the Bottom Line, will present the benefits of a cashless payment and wireless telemetry platform. Part of Lawlor’s presentation will also include snippets from USAT’s 2013 Cashless Knowledge Base that supports the perspective that total sales and volumes benefit if customers…

MondayApr 22, 2013 8:30 am

GigaMedia Ltd. (GIGM) Announces Billy Huang Added as New Independent Director to Board

GigaMedia, a diversified provider of online games and cloud computing services, announced that Billy Huang, vice president of The Walt Disney Company, will be joining GigaMedia’s board as an independent director. This addition brings GigaMedia’s board to a total of nine members, a majority of whom are independent directors. GigaMedia anticipates that the addition of Mr. Huang and his extensive experience will provide significant support to its growth strategy and perpetual commitment to increasing shareholder value. "Billy has worked with some of the most well-known companies in the world at every stage of development and his experience in building new…

MondayApr 22, 2013 8:00 am

Red Giant Entertainment, Inc. (REDG) Files Unaudited Q2, Six-Month Results

Red Giant Entertainment, a company specializing in Intellectual Property (IP) development for multiple media platforms and transmedia propagation, has filed its unaudited results for the second quarter of 2013 and highlighted various performances for the three and six month-periods ended February 28, 2013. Net income for the six months ended February 28, 2013, was $30,399, an increase of 597 percent compared to earnings of $4,364 reported in the comparable six months of 2012. Gross Profit for the six-month period increased to $84,620 from $9,708 reported in the comparable period of 2012. Second-quarter revenues increased 631 percent to $59, 591 compared…

FridayApr 19, 2013 11:36 am

Cardium Therapeutics, Inc. (CXM) Continues with Growth Strategy Implementation

When Cardium Therapeutics recently released their 2012 financial results, reflecting the company’s extensive investment required for the important introduction of Excellagen and nutraceutical initiatives, and the initiation of their Generx ASPIRE clinical study, the standout feature of the report was the extensive list of achievements put in place to drive Cardium’s long-term growth strategy. Cardium is actively advancing its Generx DNA-based angiogenic growth factor therapeutic, a one-of-a-kind treatment for heart blood flow problems which, unlike other treatments, actually stimulates blood vessel growth in the heart. Closer to market is the company’s Excellagen wound treatment product, which will eventually help support…

Site Search

Company Search